Related Experiment Video
Updated: Jun 24, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues
1Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea; Department of Biomedical Science, General Graduate School, CHA University, Pocheon, Republic of Korea.
Abstract:
Ferroptosis, a novel form of regulated cell death characterized by iron-mediated lipid peroxidation, holds immense potential in cancer therapeutics due to its role in tumor progression and resistance. This review predominantly explores the intricate relationship between ferroptosis and cholesterol metabolism pathways, mainly focusing on the cholesterol biosynthesis pathway. This review highlights the therapeutic implications of targeting cholesterol metabolism pathways for cancer treatment by delving into the mechanisms underlying ferroptosis regulation. Strategies such as inhibiting HMG-CoA reductase and suppressing squalene synthesis offer promising avenues for inducing ferroptosis in cancer cells. Moreover, insights into targeting the 7-dehydrocholesterol pathway provide novel perspectives on modulating ferroptosis susceptibility and managing ferroptosis-associated diseases. Understanding the interplay between ferroptosis and cholesterol metabolism pathways underscores the potential of lipid metabolism modulation as an innovative therapeutic approach in cancer treatment.
Insights
Ferroptosis, a cell death process involving iron and lipid peroxidation, can be targeted by modulating cholesterol metabolism. Inhibiting cholesterol synthesis offers a novel therapeutic strategy for cancer treatment.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Ferroptosis is a regulated cell death pathway driven by iron-dependent lipid peroxidation.
- This process is implicated in tumor progression and resistance to cancer therapies.
- Cholesterol metabolism pathways are increasingly recognized for their role in cancer cell survival and death.
Purpose of the Study:
- To review the relationship between ferroptosis and cholesterol metabolism, focusing on the biosynthesis pathway.
- To explore therapeutic strategies targeting cholesterol metabolism for inducing ferroptosis in cancer.
- To provide insights into novel approaches for modulating ferroptosis and associated diseases.
Main Methods:
- Literature review focusing on ferroptosis and cholesterol metabolism.
- Analysis of mechanisms linking lipid peroxidation and cholesterol biosynthesis.
- Examination of therapeutic targets within cholesterol pathways.
Main Results:
- Cholesterol biosynthesis pathways significantly influence ferroptosis.
- Inhibiting key enzymes like HMG-CoA reductase can induce ferroptosis.
- Targeting the 7-dehydrocholesterol pathway offers new ways to control ferroptosis.
Conclusions:
- Modulating cholesterol metabolism presents a promising therapeutic avenue for cancer.
- Targeting lipid metabolism, particularly cholesterol pathways, can induce ferroptosis in cancer cells.
- Understanding ferroptosis-cholesterol interplay is crucial for developing innovative cancer treatments.
More Related Videos
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Molecular Chaperones and Protein Folding
The...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Drugs that Stabilize Microtubules

